How much funding has Disc Medicine raised?

Disc Medicine has raised $202.5M in total funding, most recently a Venture Round.

Who are Disc Medicine's investors?

Disc Medicine's investors include Bain Capital Life Sciences, OrbiMed, Atlas Venture, Access Industries, Novo Holdings A/S.

When was Disc Medicine founded?

Disc Medicine was founded in 2021.

Where is Disc Medicine headquartered?

Disc Medicine is headquartered in Watertown, Massachusetts, United States.

What industry is Disc Medicine in?

Disc Medicine operates in Biotech, Healthcare.

How many employees does Disc Medicine have?

Disc Medicine has 51-200 employees.

Disc Medicine

IPO

Harnessing Breakthrough Science to Advance Hematology Care

Public · Watertown, United States · Founded 2021 · $202.5M raised

Biotech

Healthcare

Headquarters: Watertown, Massachusetts
Employees: 51–200
Founded: 2021
Business Model: B2B
Website: discmedicine.com

Total Funding: $202.5M
Last Round: $62.5M Venture RoundFeb 2023
Rounds: 3
Type: Public

About

Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for hematologic diseases. The company applies new insights in heme biosynthesis and iron metabolism to develop first-in-class therapies, including bitopertin for erythropoietic protoporphyria and DISC-0974 for myelofibrosis-associated anemia. Disc Medicine is listed on Nasdaq under the ticker IRON.

Summary

Disc Medicine is a Biotech company based in Watertown, United States, founded in 2021. It has raised $202.5M in total across 3 rounds, most recently a $62.5M Venture Round round in Feb 2023. Investors include Bain Capital Life Sciences, OrbiMed and Atlas Venture.

LinkedIn X (Twitter)